Home » Experts » Dr Dr Jame Abraham
Expert Profile

Dr Jame Abraham

Director
Breast Oncology Program at Taussig Cancer Institute and Co-director of the Cleveland Clinic Comprehensive Breast Cancer Program.

Jame Abraham, MD, is Director of the Breast Oncology Program at Taussig Cancer Institute and co-director of the Cleveland Clinic Comprehensive Breast Cancer Program. Dr. Abraham is also a professor of medicine at Cleveland Clinic Lerner College of Medicine.
Dr. Abraham completed his residency at the University Of Connecticut School Of Medicine, followed by a Medical Oncology fellowship from the National Cancer Institute (NCI) and Hematology Fellowship from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Dr. Abraham earned his medical degree from Calicut Medical College, India.
At the NCI, he was the study chair of several early-phase clinical trials that included novel treatment for breast cancer such as Ixabepilone, which was approved by FDA in 2007. During his fellowship, Dr. Abraham edited the first edition of Bethesda Handbook of Oncology (Lippincott Williams and Wilkins) one of the best-selling oncology textbooks in the world. Now it is considered the standard textbook by many universities and hospitals located across the world.
After finishing fellowship, Dr. Abraham joined West Virginia University in 2001 as an Assistant Professor. He was appointed Chief of Hematology/Oncology in 2005. He was later appointed as the first Bonnie Wells Wilson Distinguished Professor of Breast Cancer Research, and Professor of Medicine of West Virginia University (WVU).
At WVU, Dr. Abraham established the comprehensive breast cancer program. He received a grant from Department of Defense (Idea Award and Career Development Award) to study chemotherapy-induced cognitive impairment, and the Excellence in Clinical Award in Medicine from the Dean of the School of Medicine. He received an award from the President of India for outstanding contribution to Medicine in 2009.
In 2013, Dr. Abraham joined Cleveland Clinic as director of Breast Oncology Program, where he leads several national and local clinical trials to find better treatment options for early stage, metastatic, triple negative and her-2 positive breast cancer patients. He is the vice chair of the Research Review Committee for the National Surgical Adjuvant Breast and Bowel Project NSABP and a member of the scientific advisory board. He is the national Principal Investigator of the NSABP FB -10 (Neratinib and TDM-1) clinical trial.
Dr. Abraham’s primary focus and passion is taking care of patients with breast cancer. He has been selected by Cleveland Magazine and Newsweek as the top oncologist locally and nationally, respectively.
Please follow Dr. Abraham at @jamecancerdoc

 

................... Advertisement ...................

   

FAQ

ASK OUR EXPERTS

Using 0 of 1024 Possible characters
Choose Topic

Latest stories

Swine Flu Kills 11 In Nagpur, 4 In Indore: Tips To Prevent Swine Flu

Fri, 22 Sep 2017 17:00:13 IST
As many as 11 people died of swine flu in the Nagpur division in the past two days, taking the death toll 73 for the year, whereas four deaths were reported in Indore in a matter of past 24 hours.

Breathing Dirty Air May Lead To Kidney Failure: Study

Fri, 22 Sep 2017 16:00:58 IST
Air pollution may increase the risk of chronic kidney disease, which can lead to the failure of the organ, a study has warned.

Sexual Touch At An Early Age May Lead To Early Puberty

Fri, 22 Sep 2017 15:00:02 IST
German researchers found that women who were touched on their genitals at a young age experience changes in their brain and that touch triggers puberty.

Moderate Physical Activity For A Healthy Heart, Longer Life

Fri, 22 Sep 2017 14:00:23 IST
A recent study concludes that 1 in every 12 global deaths could be prevented, if all of us adhered to at-least 30 minutes of exercise each day, or 2.5 hours in week. Read on to know moderate exercising could help prevent heart disease and help you live longer.

11 Infants Being Treated For The E-Coli Infection At PGIMER

Fri, 22 Sep 2017 13:00:42 IST
The PGIMER (Post Graduate Institute of Medical Education and Research) battles against the outbreak of E-Coli infection in its Neonatal ICU. 1 infants are getting treatment for this infection at the moment, hospital sources reveal.